Emixustat Hydrochloride
Blinding Retinal Disease (unspecified)
Compassionate Use / Late-stageActive - GMP manufacturing initiated
Key Facts
Indication
Blinding Retinal Disease (unspecified)
Phase
Compassionate Use / Late-stage
Status
Active - GMP manufacturing initiated
Company
About Kubota Pharmaceutical
A Japanese biotech company developing small molecule drugs and devices to treat and cure blinding diseases.
View full company profile